• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA TERUMO GLIDECATH CATHETER; CATHETER, INTRAVASCULAR, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA TERUMO GLIDECATH CATHETER; CATHETER, INTRAVASCULAR, DIAGNOSTIC Back to Search Results
Model Number N/A
Device Problem Material Rupture (1546)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/07/2022
Event Type  malfunction  
Event Description
Terumo medical received a user facility medwatch report # (b)(4).The event description states: "staff reported the terumo catheter "ruptured" during injection in a diagnostic cerebral angiogram procedure.No injury was identified related to the event.The catheter remains intact during the injection process.Preexisting characteristics that may have contributed to the event: hypertension.".
 
Manufacturer Narrative
Lot number: requested, unknown.Expiration date: unknown due to unknown lot number.Implanted date: device was not implanted.Occupation: master of science in nursing, registered nurse (msn, rn).Device manufacture date: unknown due to unknown lot number.Since the actual sample was not returned to ashitaka factory, the investigation of it was unable to be performed.Review of the manufacturing record and the shipping inspection record could not be performed since the involved lot number was unknown.Ifu of this product includes the following warning."before starting infusion, verify that the catheter has not been kinked or blocked.Failure to abide by this warning may cause the catheter to break/rupture/separate, resulting in damage to the vessel." regarding this case, it was inferred that the actual product was ruptured due to excessive pressure applied for some reason.However, since the actual product could not be investigated, and the record inspections could not be performed due to the unknown lot number, the cause of occurrence could not be identified.(b)(4).
 
Manufacturer Narrative
This report is being submitted as follow up no.1 to provide correction to section b4.The b4 date was inadvertently entered as 03/02/2022 instead of 03/03/2022.
 
Manufacturer Narrative
This report is being submitted as follow up no.2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO GLIDECATH CATHETER
Type of Device
CATHETER, INTRAVASCULAR, DIAGNOSTIC
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
stephanie handy
reg. no. 2243441
950 elkton blvd
elkton, MD 21921
9499890491
MDR Report Key13659118
MDR Text Key289614982
Report Number9681834-2022-00026
Device Sequence Number1
Product Code DQO
UDI-Device Identifier04987350772534
UDI-Public04987350772534
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K915414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberCG511
Device Lot NumberYA25110A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-